Mechanisms of action Tirzepatide is a dual GLP-1/GIP receptor agonist that occupies GLP-1 and GIP receptors simultaneously to improve metabolic health
doi:10.1016/j.fertnstert.2021.02.009
SGLT2 inhibitors represent the most evidence-based pharmacologic therapy that can be readily initiated during hospitalization, whereas agents such as GLP-1 receptor agonists are more appropriately incorporated into outpatient management strategies
Collagen, elastin, hydration balance, barrier function, inflammation patterns, circulation, and normal tissue turnover all influence firmness, texture, and visible aging over time
It is likely to increase the production of the enzyme AMPK, which improves the body's ability to use carbohydrates as an energy source